NCT01149850 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT01149850
Title	Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma
Recruitment	Completed
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	Jonsson Comprehensive Cancer Center
Indications	gliosarcoma glioblastoma
Therapies	Bevacizumab + Temozolomide
Age Groups:	senior
Covered Countries	USA

Filter rows:

Showing 1 to 3 of 3 entries

Facility	City	State	Zip	Country	Details
Kaiser Foundation Hospital	Los Angeles	California	90027	United States	Details
Kaiser Permanente at San Diego	San Diego	California	92120	United States	Details
University of California, Los Angeles	Los Angeles	California	90095	United States	Details

Showing 1 to 3 of 3 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT01149850Clinical Trial Detail